GlaxoSmithKline Gets 79% Tenders for Human Genome Sciences Offer
30 Juli 2012 - 3:06PM
Dow Jones News
LONDON--Research-based pharmaceutical and healthcare company
GlaxoSmithKline PLC (GSKl.LN) said Monday that the initial tender
offer for Human Genome Sciences Inc (HGSI) expired 0400 GMT on July
26, and at that time 158.61 million shares, or 79%, had been
validly tendered and not withdrawn.
MAIN FACTS:
-An additional 9.16 million Human Genome shares, or 4%, were
tendered subject to guaranteed delivery procedures.
-GlaxoSmithKline shares at 1235 GMT up 17 pence, or 1.14%, at
1460 pence valuing the company at 72.03 billion pounds.
-Write to Ian Walker at ian.walker@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Human Genome Sciences (NASDAQ:HGSI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Human Genome Sciences (NASDAQ:HGSI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Human Genome Sciences, Inc. (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Human Genome Sciences Inc. News-Artikel